Revlimid 25 mg is prescribed by hematologists and oncologists for the treatment of the following diseases: 🔹 Multiple Myeloma: As part of combination therapy with dexamethasone or as maintenance therapy after stem cell transplantation. 🔹 Myelodysplastic Syndromes (MDS): For the treatment of patients with anemia caused by a cytogenetic abnormality (5q deletion). 🔹 Mantle Cell Lymphoma: In cases of relapse or disease progression after prior therapy. 🔹 Follicular Lymphoma: In combination with rituximab.

Dosage and administration

Sales Form: 1 pack contains 21 capsules of 25 mg (a standard course for one cycle).⚠️ INSTRUCTIONS FOR USE: Dosage Regimen: The schedule depends on the treatment protocol. It is often prescribed as 1 capsule (25 mg) per day for 21 days, followed by a 7-day break. Method: Capsules should be taken whole, without breaking or chewing, at the same time each day, regardless of food intake. Blood Monitoring: At the start of therapy, weekly monitoring of complete blood count (white blood cells, platelets) is required for dose adjustment if necessary. Thrombosis Prevention: Often prescribed alongside blood-thinning medications (aspirin, anticoagulants).

⛔ Pregnancy (CRITICAL): Lenalidomide has a potent teratogenic effect. It is strictly contraindicated in pregnant women. Both women and men must follow the strict rules of the pregnancy prevention program. ⛔ Lactation: Breastfeeding must be discontinued. ⛔ Hypersensitivity: Allergy to lenalidomide or thalidomide (risk of severe skin reactions). ⛔ Age: Safety of use in children under 18 years of age has not been established.

When taking Revlimid 25 mg, the following adverse reactions may occur: 🩸 Hematology: Neutropenia (low white blood cell count), thrombocytopenia, anemia. 🚑 Thromboembolism: Increased risk of blood clots in deep veins or lungs. 🌿 Skin Reactions: Skin itching, rash, dry skin. 🤢 GI Tract: Diarrhea or constipation, nausea, decreased appetite. 🥱 General: Fatigue, muscle cramps, swelling of the extremities. ⚠️ Important: If shortness of breath, chest pain, or leg swelling occurs, seek medical attention immediately.

Revlimid 25 — Lenalidomide 25 mg, 21 pcs, Celgene

100% original product

Active ingredient

Lenalidomide

Manufacturer

Celgene

Dosage

25 mg

Dosage form Capsules

Capsules per pack 21

Revlimid 25 — Lenalidomide 25 mg (21 Capsules)

Name: Revlimid 25
Brand: Celgene
SKU: PROD-284
Price: 49170 UAH
Availability: PreOrder

49170₴ ~~53640₴~~ -8% On order · from 7 days

Analogues

Lenalid 25 Revlimid 25 Revlixen 25

Dosage

10 mg 25 mg

Active ingredient

Lenalidomide

Manufacturer

Celgene

Dosage

25 mg

Dosage form Capsules

Capsules per pack 21

Revlimid 25 mg (Lenalidomide) is a potent antineoplastic immunomodulator that has revolutionized the treatment of several onco-hematological diseases. Lenalidomide possesses a triple mechanism of action: it directly inhibits the growth of abnormal cells, blocks the development of blood vessels that nourish the tumor (anti-angiogenic effect), and activates the patient's own immunity to fight cancer.

Manufacturer: Celgene. Revlimid in the maximum dosage of 25 mg is a cornerstone of first-line therapy and treatment for relapsed multiple myeloma, demonstrating high efficacy in achieving deep and long-term remission.

Key Features:

✅ Multifactorial Mechanism: Attacks the tumor from several sides simultaneously, reducing the risk of developing resistance.
✅ Targeted Therapy: Belongs to the class of IMiDs (immunomodulatory drugs), specifically targeting the tumor microenvironment.
✅ Convenience: Oral administration (capsules) allows for treatment at home under medical supervision.

Revlimid 25 mg is prescribed by hematologists and oncologists for the treatment of the following diseases:

🔹 Multiple Myeloma: As part of combination therapy with dexamethasone or as maintenance therapy after stem cell transplantation.
🔹 Myelodysplastic Syndromes (MDS): For the treatment of patients with anemia caused by a cytogenetic abnormality (5q deletion).
🔹 Mantle Cell Lymphoma: In cases of relapse or disease progression after prior therapy.
🔹 Follicular Lymphoma: In combination with rituximab.

Sales Form: 1 pack contains 21 capsules of 25 mg (a standard course for one cycle).

⚠️ INSTRUCTIONS FOR USE:

Dosage Regimen: The schedule depends on the treatment protocol. It is often prescribed as 1 capsule (25 mg) per day for 21 days, followed by a 7-day break.
Method: Capsules should be taken whole, without breaking or chewing, at the same time each day, regardless of food intake.
Blood Monitoring: At the start of therapy, weekly monitoring of complete blood count (white blood cells, platelets) is required for dose adjustment if necessary.
Thrombosis Prevention: Often prescribed alongside blood-thinning medications (aspirin, anticoagulants).

⛔ Pregnancy (CRITICAL): Lenalidomide has a potent teratogenic effect. It is strictly contraindicated in pregnant women. Both women and men must follow the strict rules of the pregnancy prevention program.
⛔ Lactation: Breastfeeding must be discontinued.
⛔ Hypersensitivity: Allergy to lenalidomide or thalidomide (risk of severe skin reactions).
⛔ Age: Safety of use in children under 18 years of age has not been established.

When taking Revlimid 25 mg, the following adverse reactions may occur:

🩸 Hematology: Neutropenia (low white blood cell count), thrombocytopenia, anemia.
🚑 Thromboembolism: Increased risk of blood clots in deep veins or lungs.
🌿 Skin Reactions: Skin itching, rash, dry skin.
🤢 GI Tract: Diarrhea or constipation, nausea, decreased appetite.
🥱 General: Fatigue, muscle cramps, swelling of the extremities.
⚠️ Important: If shortness of breath, chest pain, or leg swelling occurs, seek medical attention immediately.

On order · from 7 days

100% original product

Delivery across Ukraine

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 23.04.2026